SAMANTHA SWAN: Open Payments
NPI 1497431977 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 38 payments from 12 companies in 2025. Trend: 2023 $779 · 2024 $864 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 9 | $153 |
| 180 Medical, Inc. | 7 | $137 |
| Sumitomo Pharma America, Inc. | 6 | $121 |
| ABBVIE INC. | 4 | $71 |
| Olympus America Inc. | 3 | $49 |
| PFIZER INC. | 2 | $40 |
| Janssen Biotech, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $27 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| Medtronic, Inc. | 1 | $21 |
Products named: GEMTESA, AVEED, XTANDI, XIAFLEX, BOTOX, iTIND System, ERLEADA, ADSTILADRIN.
Industry payments across UT — which companies pay providers there.
